Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Medicine|June 30, 2009
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune diseaseEugene Y Chiang, Ganesh A Kolumam, Xin Yu, et al.
Neurobiology of Disease|December 12, 2018
Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALSArundhati Sengupta-Ghosh, Sara L Dominguez, Luke Xie, et al.
Cancer Cell|July 13, 2013
A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewalYanyan Zheng, Cecile C de la Cruz, Leanne C Sayles, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
Cell Reports|August 22, 2019
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and TauopathyTiffany Wu, Borislav Dejanovic, Vineela D Gandham, et al.
Neoplasia (New York, N.Y.)|July 2, 2013
Multimodal microvascular imaging reveals that selective inhibition of class I PI3K is sufficient to induce an antivascular responseDeepak Sampath, Jason Oeh, Shelby K Wyatt, et al.
The Journal of Clinical Investigation|August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacyLeisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Nature Chemical Biology|November 30, 2010
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritisJulie A Di Paolo, Tao Huang, Mercedesz Balazs, et al.
Science Signaling|April 20, 2017
The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammationKate Senger, Victoria C Pham, Eugene Varfolomeev, et al.
The Journal of Experimental Medicine|February 23, 2021
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatmentAlessia Balestrini, Victory Joseph, Michelle Dourado, et al.
Pageof 2